Form 4: Vor Biopharma Inc. Executive Chakraborty Sells Shares to Cover Tax Obligations

Tirtha Chakraborty, Chief Scientific Officer of Vor Biopharma Inc., disposed of 875 shares of common stock on May 6, 2024, to cover tax withholding obligations related to the settlement of restricted stock units.

Summary

• On May 6, 2024, Tirtha Chakraborty, the Chief Scientific Officer of Vor Biopharma Inc., disposed of 875 shares of common stock.
• The transaction was executed to satisfy tax withholding obligations associated with the settlement of restricted stock units.
• The shares were sold at a price of $1.75 per share.
• Following the transaction, Chakraborty directly owns 179,233 shares of Vor Biopharma Inc.
• The transaction was reported on a Form 4 filing with the Securities and Exchange Commission (SEC).

Sentiment

Score: 5

Explanation: The document is a routine disclosure of a stock transaction by a company executive to cover tax obligations, which is neither particularly positive nor negative.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, such as officers and directors, trade their company's stock. These filings provide transparency to the market regarding insider transactions.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on stakeholders as it is a routine sale of shares to cover tax obligations.

Key Dates